| 3739 |
122: Increase, GR activation |
450: Decrease, VLDL export capacity |
Feb 12, 2026 |
Feb 12, 2026 |
None
|
| 3720 |
2409: Decrease, 11β-HSD2 activity |
2119: Increase, Insulin resistance |
Feb 10, 2026 |
Feb 10, 2026 |
None
|
| 3722 |
2408: Increase, Adipose lipolysis |
115: Increase, FA influx |
Feb 10, 2026 |
Feb 10, 2026 |
None
|
| 3723 |
115: Increase, FA influx |
459: Increase, Liver steatosis |
Feb 10, 2026 |
Feb 10, 2026 |
None
|
| 3719 |
1545: Decrease in mitochondrial oxidative phosphorylation |
1771: Decrease, ATP pool |
Feb 4, 2026 |
Feb 4, 2026 |
None
|
| 3771 |
97: Alkylation, DNA |
1757: Reduce, Sperm count |
Apr 7, 2026 |
Apr 7, 2026 |
None
|
| 3731 |
2409: Decrease, 11β-HSD2 activity |
450: Decrease, VLDL export capacity |
Feb 11, 2026 |
Feb 11, 2026 |
None
|
| 3732 |
1271: Activation of TGF-β signaling |
1606: Activation, Stellate cell |
Feb 11, 2026 |
Feb 11, 2026 |
None
|
| 3733 |
1606: Activation, Stellate cell |
68: Increase, Collagen accumulation |
Feb 11, 2026 |
Feb 11, 2026 |
None
|
| 3734 |
2409: Decrease, 11β-HSD2 activity |
1306: Increase, De novo lipogenesis |
Feb 11, 2026 |
Feb 11, 2026 |
None
|
| 3685 |
1417: NFE2/Nrf2 repression |
2386: Lipid-peroxidation overload |
Nov 4, 2025 |
Nov 4, 2025 |
None
|
| 3686 |
2386: Lipid-peroxidation overload |
1994: Ferroptosis |
Nov 4, 2025 |
Nov 4, 2025 |
None
|
| 3697 |
1507: Activation of PPARγ |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Dec 3, 2025 |
Dec 3, 2025 |
None
|
| 3532 |
36: Inhibition, Aromatase |
219: Reduction, Plasma 17beta-estradiol concentrations |
Apr 29, 2025 |
Apr 29, 2025 |
None
|
| 3564 |
2339: Intracellular copper, increased |
1632: Increase in RONS |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3565 |
1632: Increase in RONS |
1767: Increase, Protein oxidation |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3560 |
111: Agonism, Estrogen receptor |
1066: Promotion, SIX1 positive progenitor cells in endometrium |
Aug 5, 2025 |
Aug 5, 2025 |
None
|
| 3559 |
1472: Decrease, ATP production |
360: Decrease, Population growth rate |
Aug 5, 2025 |
Feb 27, 2026 |
None
|
| 3566 |
1632: Increase in RONS |
1445: Increase, LPO |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3567 |
1632: Increase in RONS |
1634: Increase, Oxidative DNA damage |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3568 |
1767: Increase, Protein oxidation |
1994: Ferroptosis |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3569 |
1445: Increase, LPO |
1994: Ferroptosis |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3570 |
1634: Increase, Oxidative DNA damage |
1262: Apoptosis |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3575 |
2342: Fe-S cluster assembly, impaired |
1477: OXPHOS, decreased |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3542 |
2325: Decreased number of LT CD8+ cells |
1971: tumor growth |
Jun 10, 2025 |
Jun 10, 2025 |
None
|